Welcome to precisionFDA

The term _Personalized Medicine_ began appearing in published literature around 1999, described as a practice enabling physicians to identify and treat patients based on their unique characteristics (Jain, 2002). Somewhere in the course of its history, the Personalized Medicine revolution was rebranded as the Precision Medicine revolution (Doltson & Søgaard, 2011). Primary among reasons cited for this rebranding effort was addressing public misconception of the word "personalized", which suggested an ability to tailor-make drugs for each patient. _Precision Medicine_ seemed better suited to convey the use of new molecular technologies for fine-grained disease classification. Indeed, it was our newfound ability to describe a disease in millions of dimensions (i.e., using its molecular signature) that would drive better health outcomes. The new phrase focused the public's intuition on next-generation diagnostic technologies rather than bespoke therapeutic technologies. [read more at the full blog]